📰 Brian Coe News
Page 5 - Brian Coe News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Brian Coe. Real-time updates on events, politics, business and more.
January 18, 2022
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS). Such...
January 17, 2022
17.01.2022 - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Talis Biomedical Corporation (“Talis”) (NASDAQ: TLIS). The action charges Talis with violations of the federal ...
January 16, 2022
/PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Talis Biomedical Corporation (NASDAQ: TLIS) common stock pursuant...
January 15, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
January 15, 2022
RADNOR, Pa., Jan. 14, 2022 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action...
January 15, 2022
/PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Talis...
January 15, 2022
/PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Talis Biomedical Corporation (NASDAQ: TLIS) common stock pursuant...
January 15, 2022
/PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Talis...
January 11, 2022
11.01.2022 - Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming March 8, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Talis Biomedical Corporation (“Talis” ... Seite 1
January 11, 2022
/PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Talis Biomedical Corporation (NASDAQ: TLIS) common stock pursuant...